We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Top Buys

Rank Stock Value
1
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$520M
2
UNH icon
UnitedHealth
UNH
+$332M
3
ADI icon
Analog Devices
ADI
+$320M
4
FIS icon
Fidelity National Information Services
FIS
+$265M
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$237M

Top Sells

Rank Stock Value
1
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$516M
2
SMMV icon
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
+$512M
3
CSCO icon
Cisco
CSCO
+$348M
4
AAPL icon
Apple
AAPL
+$162M
5
DVN icon
Devon Energy
DVN
+$142M

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBX
3901
Wallbox
WBX
$83.9M
$12.2K ﹤0.01%
+500
New +$13.7K
FTH
3902
Faeth Therapeutics
FTH
$760M
$12K ﹤0.01%
1,000
+300
+43% +$3.66K
MLSS icon
3903
Milestone Scientific
MLSS
$38M
$10.9K ﹤0.01%
12,000
– –
VXRT
3904
DELISTED
Vaxart
VXRT
$10.4K ﹤0.01%
12,279
-4,447
-27% -$3.4K
BNAI
3905
Brand Engagement Network
BNAI
$82.3M
$10.4K ﹤0.01%
+1,000
New +$19.4K
VIVS
3906
VivoSim Labs
VIVS
$1.32M
$9.99K ﹤0.01%
1,635
– –
SES icon
3907
SES AI
SES
$196M
$9.6K ﹤0.01%
15,000
– –
SKYX icon
3908
SKYX Platforms
SKYX
$155M
$8.48K ﹤0.01%
10,000
– –
AZ icon
3909
A2Z Smart Technologies
AZ
$264M
$8K ﹤0.01%
4,000
– –
SENS icon
3910
Senseonics Holdings Inc
SENS
$256M
$6.92K ﹤0.01%
990
+5
+0.5% +$40
EVA
3911
DELISTED
Enviva Inc.
EVA
$6.81K ﹤0.01%
16,823
+757
+5% +$330
KULR icon
3912
KULR Technology Group
KULR
$117M
$5.76K ﹤0.01%
2,526
– –
GORO icon
3913
Goldgroup Mining Inc.
GORO
$150M
$5.7K ﹤0.01%
16,308
– –
DWTX
3914
Dogwood Therapeutics
DWTX
$50.8M
$5.2K ﹤0.01%
1,224
+24
+2% +$124
JOB icon
3915
GEE Group
JOB
$22.8M
$4.69K ﹤0.01%
18,000
– –
CGTX icon
3916
Cognition Therapeutics
CGTX
$82.7M
$4.69K ﹤0.01%
10,000
– –
SOAR icon
3917
Volato Group
SOAR
$7.13M
$3.92K ﹤0.01%
400
– –
NEXI
3918
DELISTED
NexImmune, Inc. Common Stock
NEXI
$2.7K ﹤0.01%
10,804
– –
BFI
3919
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$2.59K ﹤0.01%
71,881
– –
MVST icon
3920
Microvast
MVST
$256M
$2.5K ﹤0.01%
10,000
– –
NUVO
3921
DELISTED
Holdco Nuvo Group D.G Ltd. Ordinary Shares
NUVO
$1.71K ﹤0.01%
244,207
+144,207
+144% +$100K
ACI icon
3922
Albertsons Companies
ACI
$5.67B
– –
-56,190
Closed -$1.11M
ACLS icon
3923
Axcelis
ACLS
$3.69B
– –
-1,778
Closed -$253K
ADAP
3924
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-10,218
Closed -$9.96K
AFB
3925
AllianceBernstein National Municipal Income Fund
AFB
$314M
– –
-10,894
Closed -$121K
155 156
157
158 159

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.